Project Details
Description
A Placebo Controlled, Randomized, Double-Blind Phase II Clinical Trial to Evaluate Tolerability, Safety and Efficacy Endpoints after Administration of Recombinant Human I
| Status | Finished |
|---|---|
| Effective start/end date | 8/23/07 → 8/22/11 |
Funding
- INSMED INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.